Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Mild to Moderate Alzheimer's Disease (LEADe)
NCT00151502Phase 3Completed
- Sponsor
- Viatris
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of atorvastatin in Alzheimer's disease (AD), sponsored by Viatris. Started Nov 2002; status: completed.
02
Drugs
atorvastatin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00151502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151502.